AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
"The next phase for Miami will be an increase in exits"
2
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
3
Once $5 billion IPO bound, Cybereason merges with Trustwave amid decline
4
Is your solitaire opponent actually a bot?
5
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
More news

Nasdaq

5 stories about Nasdaq
מנכ"ל פורסקאוט מייקל דסיזאר

ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO

19.10.17|Dror Reich
The information security company aims to raise $96-$105.6 million in a Nasdaq IPO
default image

Israel’s Flagship Company Stayed its Course

16.10.17|Dror Reich
The share price of veteran cybersecurity company Check Point reached a record-breaking $120 over the weekend
מנכ"ל פורסקאוט מייקל דסיזאר

Forescout Files For $100 Million Nasdaq IPO

04.10.17|Dror Reich
Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan
default image

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
default image

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year
Previous Articles